These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. RNA-Based Therapeutic Strategies for Inherited Retinal Dystrophies. Garanto A Adv Exp Med Biol; 2019; 1185():71-77. PubMed ID: 31884591 [TBL] [Abstract][Full Text] [Related]
48. Antisense oligonucleotides: the state of the art. Aboul-Fadl T Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780 [TBL] [Abstract][Full Text] [Related]
49. Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides. Bertoni C Front Biosci; 2008 Jan; 13():517-27. PubMed ID: 17981565 [TBL] [Abstract][Full Text] [Related]
50. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases. Bejar N; Tat TT; Kiss DL Curr Atheroscler Rep; 2022 May; 24(5):307-321. PubMed ID: 35364795 [TBL] [Abstract][Full Text] [Related]
51. Modification of pre-mRNA splicing by antisense oligonucleotides. Kole R Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712 [TBL] [Abstract][Full Text] [Related]
52. Antisense therapy for angioplasty restenosis. Some critical considerations. Bennett MR; Schwartz SM Circulation; 1995 Oct; 92(7):1981-93. PubMed ID: 7671381 [TBL] [Abstract][Full Text] [Related]
53. Oligonucleotide therapeutics in cancer. Wan J; Bauman JA; Graziewicz MA; Sazani P; Kole R Cancer Treat Res; 2013; 158():213-33. PubMed ID: 24222360 [TBL] [Abstract][Full Text] [Related]
54. RNA therapeutics: updates and future potential. Zhang C; Zhang B Sci China Life Sci; 2023 Jan; 66(1):12-30. PubMed ID: 36100838 [TBL] [Abstract][Full Text] [Related]
56. RNA base editors: The emerging approach of RNA therapeutics. Song J; Luo N; Dong L; Peng J; Yi C Wiley Interdiscip Rev RNA; 2024; 15(2):e1844. PubMed ID: 38576085 [TBL] [Abstract][Full Text] [Related]
57. Recent applications of RNA therapeutic in clinics. Ha Thi HT; Than VT Prog Mol Biol Transl Sci; 2024; 203():115-150. PubMed ID: 38359994 [TBL] [Abstract][Full Text] [Related]
58. Targeting the lung using siRNA and antisense based oligonucleotides. Moschos SA; Spinks K; Williams AE; Lindsay MA Curr Pharm Des; 2008; 14(34):3620-7. PubMed ID: 19075738 [TBL] [Abstract][Full Text] [Related]
59. The current landscape of nucleic acid therapeutics. Kulkarni JA; Witzigmann D; Thomson SB; Chen S; Leavitt BR; Cullis PR; van der Meel R Nat Nanotechnol; 2021 Jun; 16(6):630-643. PubMed ID: 34059811 [TBL] [Abstract][Full Text] [Related]